Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: Are class solutions obsolete?

被引:1
|
作者
Everitt, S. [1 ,4 ]
Schneider-Kolsky, M. [4 ]
Yuen, K. [3 ]
Budd, R. [4 ]
Mac Manus, M. [2 ]
机构
[1] Monash Univ, Peter MacCallum Canc Ctr, Dept Radiat Therapy, Melbourne, Vic 8006, Australia
[2] Monash Univ, Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic 8006, Australia
[3] Monash Univ, Peter MacCallum Canc Ctr, Ctr Biostat & Clin Trials, Melbourne, Vic 8006, Australia
[4] Monash Univ, Dept Med Imaging & Radiat Sci, Melbourne, Vic 8006, Australia
关键词
dose optimization; non-small-cell lung cancer; positron emission tomography; three-dimensional conformal radiation therapy;
D O I
10.1111/j.1440-1673.2008.01937.x
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
This study investigated the maximum theoretical radiation dose that could safely be delivered to 20 patients diagnosed with non-small-cell lung cancer. Two three-dimensional conformal radiation therapy (RT) class-solution techniques (A and B) and an individualized three-dimensional conformal RT technique (C) were compared at the standard dose of 60 Gy (part I). Dose escalation was then attempted for each technique successfully at 60 Gy, constrained by predetermined limits for lung and spinal canal (part II). Part I and part II data were reanalysed to include oesophageal dose constraints (part III). In part I, 60 Gy was successfully planned using techniques A, B and C in 19 (95%), 18 (90%) and 20 (100%) patients, respectively. The mean escalated dose attainable for part II using techniques A, B and C were 76.4, 74 and 97.8 Gy, respectively (P < 0.0005). One (5%) patient was successfully planned for 120 Gy using techniques A and B, whereas four (20%) were successfully planned using technique C. Following the inclusion of additional constraints applied to the oesophagus in part III, the amount of escalated dose remained the same for all patients who were successfully planned at 60 Gy apart from two patients when technique C was applied. In conclusion, individualized three-dimensional conformal RT facilitated greater dose conformation and higher escalation of dose in most patients. With modern planning tools, simple class solutions are obsolete for conventional dose radical RT in non-small-cell lung cancer. Highly individualized conformal planning is essential for dose escalation.
引用
收藏
页码:168 / 177
页数:10
相关论文
共 50 条
  • [1] Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation
    Klopp, Ann Hoge
    Chang, Joe Y.
    Tucker, Susan L.
    Sulman, Erik P.
    Balter, Peter A.
    HelenLiu, H.
    Bucci, M. Kara
    Macapinlac, Homer A.
    Komaki, Ritsuko
    Cox, James D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (05): : 1409 - 1416
  • [2] Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography
    Lardinois, D
    Weder, W
    Hany, TF
    Kamel, EM
    Korom, S
    Seifert, B
    von Schulthess, GK
    Steinert, HC
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (25): : 2500 - 2507
  • [3] Positron Emission Tomography/Computed Tomography Thoracic Nodal Staging of Non-Small-Cell Lung Cancer
    Cheung, W. S. K.
    HONG KONG JOURNAL OF RADIOLOGY, 2023, 26 (01): : 4 - 5
  • [4] Application of novel quantitative techniques for fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer
    Wang, Duo
    Koh, Eng-Siew
    Descallar, Joseph
    Pramana, Ariyanto
    Vinod, Shalini K.
    Shon, Ivan Ho
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (04) : 349 - 358
  • [5] Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography
    Scott, WJ
    Gobar, LS
    Terry, JD
    Dewan, NA
    Sunderland, JJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (03): : 642 - 648
  • [6] Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer
    Mac Manus, MP
    Hicks, RJ
    Matthews, JP
    McKenzie, A
    Rischin, D
    Salminen, EK
    Ball, DL
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) : 1285 - 1292
  • [7] Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer
    Gondi, Vinai
    Bradley, Kristin
    Mehta, Minesh
    Howard, Andy
    Khuntia, Deepak
    Ritter, Mark
    Tome, Wolfgang
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 187 - 195
  • [8] Improvement of non-small-cell lung cancer staging by means of positron emission tomography
    Albes, JM
    Lietzenmayer, R
    Schott, U
    Schülen, E
    Wehrmann, M
    Ziemer, G
    THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (01): : 42 - 47
  • [9] Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography - Discussion
    Rusch, VW
    Scott, WJ
    Warren, WH
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (03): : 648 - 648
  • [10] Staging of non-small-cell lung cancer with positron-emission tomography.
    Miller, YE
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21): : 1571 - 1572